Latest AI and machine learning research in other cancers for healthcare professionals.
Deregulation of the protein secretory pathway (PSP) is linked to many hallmarks of cancer, such as p...
Gliomas are one of the most devastating primary brain tumors which impose significant management cha...
Background It is important to diagnose sclerotic bone lesions in order to determine treatment strate...
BACKGROUND: Radical nephroureterectomy (RNU) represents the standard of care for high grade upper tr...
PURPOSE: Nasopharyngeal carcinoma (NPC) is a category of tumors with high incidence in head-and-neck...
The tumor microenvironment (TME) within mucosal neoplastic tissue in oral cancer (ORCA) is greatly i...
Renal cell carcinoma (RCC) is the most common renal cancer in adults. The histopathologic classifica...
BACKGROUND: Targeted therapy and immunotherapy put forward higher demands for accurate lung cancer c...
OBJECTIVES: While the prevalence of active cancer patients experiencing acute stroke is increasing, ...
Endonasal surgery is a minimally invasive approach for the removal of pituitary tumors (sarcomas). I...
PURPOSE: Magnetic Resonance Imaging (MRI) provides an essential contribution in the screening, detec...
Prediction of long-term survival in patients with invasive intraductal papillary mucinous neoplasm (...
Mesenchymal stromal cells (MSCs) are multipotent cells that have great potential for regenerative me...
Background Conventional radiologic modalities perform poorly in the radiated rectum and are often un...
Three-dimensional in vitro tumor models provide more physiologically relevant responses to drugs tha...
Brain tumor classification plays an important role in clinical diagnosis and effective treatment. In...
This study addresses the core issue facing a surgical team during breast cancer surgery: quantitativ...
BACKGROUND AND PURPOSE: To explore whether a highly refined dose volume histograms (DVH) prediction ...
Deep learning models based on medical images play an increasingly important role for cancer outcome ...
Drug response differs substantially in cancer patients due to inter- and intra-tumor heterogeneity. ...